New public-private open innovation project for the repositioning of 20 drugs
A public-private open innovation project to discover new drugs based on repurposing (repositioning)- the result of a collaboration agreement between the Drug Discovery Platform (DDP) at the Barcelona Science Park (PCB) and the companies SOM Biotech and Metasbio, both located at the PCB, has obtained a grant of 441,884 Euros from the Genome Spain Foundation through the Innocash credit line. Initially, the three partners have selected therapeutic areas characterized by a high medical need and market potential, particularly central nervous system diseases, orphan diseases, and oncology.
A public-private open innovation project to discover new drugs based on repurposing (repositioning)- the result of a collaboration agreement between the Drug Discovery Platform (DDP) at the Barcelona Science Park (PCB) and the companies SOM Biotech and Metasbio, both located at the PCB, has obtained a grant of 441,884 Euros from the Genome Spain Foundation through the Innocash credit line. Initially, the three partners have selected therapeutic areas characterized by a high medical need and market potential, particularly central nervous system diseases, orphan diseases, and oncology.